Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

06. Oktober 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces a Clinical Trial for Pediatric Patients With Congenital Myasthenic Syndromes

CORAL GABLES, Fla., Oct. 06, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
09. September 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Intent to Develop a Generic Equivalent of Sabril

CORAL GABLES, Fla., Sept. 09, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
03. September 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 17th Annual Global Investment Conference

CORAL GABLES, Fla., Sept. 03, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
17. August 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Appoints Paul J. Merrigan as Chief Commercial Officer

CORAL GABLES, Fla., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
10. August 2015 16:29 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Second Quarter 2015 Financial Results and Provides Corporate Update

CORAL GABLES, Fla., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
04. August 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Tuesday, August 11th, 2015

CORAL GABLES, Fla., Aug. 04, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people...
22. Juli 2015 13:23 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)

CORAL GABLES, Fla., July 22, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
30. Juni 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Appoints Dr. Gary Ingenito as Chief Medical Officer

CORAL GABLES, Fla., June 30, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
29. Juni 2015 11:06 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Joins Russell 2000, 3000 and Global Indexes

CORAL GABLES, Fla., June 29, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
24. Juni 2015 08:03 ET | Quelle: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Encouraging Top-Line Results in Proof-of-Concept Trial of Vigabatrin in Patients With Treatment-Refractory Tourette's Disorder

CORAL GABLES, Fla., June 24, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...

Vorherige Seite

Nächste Seite